Status:
COMPLETED
Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
Lead Sponsor:
Public Health England
Conditions:
Pneumococcal Infections
Meningococcal Infections
Eligibility:
All Genders
7-11 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjug...
Eligibility Criteria
Inclusion
- Written informed consent obtained from parent or legal guardian of infant
- Age 7-11 weeks at first dose
Exclusion
- Any contraindications to vaccination as specified in the UK Handbook "Immunisation Against Infectious Disease" (Ed 1996)
- \< 7 weeks or \> 11 weeks at first dose
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
392 Patients enrolled
Trial Details
Trial ID
NCT00197808
Start Date
April 1 2005
End Date
January 1 2010
Last Update
October 1 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hertfordshire Primary Care Trusts
Welwyn Garden City, Hertfordshire, United Kingdom, AL8 6JL
2
Gloucestershire Primary Care Trusts
Gloucester, United Kingdom, GL1 3NN